Overview

Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease

Status:
Terminated
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of interferon beta-1a in maintaining remission in patients with Crohn's disease.
Phase:
Phase 2
Details
Lead Sponsor:
EMD Serono
Treatments:
Interferon beta-1a
Interferon-beta
Interferons